Results 231 to 240 of about 997,515 (336)

The Role of PI3K/AKT/mTOR Signaling in Tumor Radioresistance and Advances in Inhibitor Research. [PDF]

Int J Mol Sci
Zhan J, Jücker M.
europepmc   +1 more source

Radiotherapy in locally advanced cancer of the breast. Adjunct to standard therapy [PDF]

, 1967
Ruth Guttmann
openalex   +1 more source

Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415). [PDF]

Clin Exp Metastasis
Bozorgmehr F, Chung I, Fischer JR, Bischof M, Atmaca A, Wetzel S, Faehling M, Bottke D, Wermke M, Troost EGC, Kropf-Sanchen C, Wiegel T, Schmidt B, Stupavsky A, Engel-Riedel W, Hammer-Hellmig M, Reinmuth N, Manapov F, Grohe C, Krempien R, Schumann C, Sterzing F, Reck M, Würschmidt F, Fleckenstein J, Petroff A, Henschke S, Behnisch R, Cvetkovic J, Brückner L, Schwab C, Stenzinger A, Götze T, Kopp C, Schröder H, Debus J, Christopoulos P, Thomas M, Rieken S.   +38 more
europepmc   +1 more source

Oxygenation in Radiotherapy of Malignant Disease of the Upper Air Passages [Abridged] [PDF]

, 1964
I. Churchill‐Davidson
openalex   +1 more source

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

Molecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero, Alejandro Belmonte‐Fernández, Mónica González‐Moreno, Laura Rodríguez‐Cordero, Begoña Pérez‐Valderrama, Joaquín Herrero‐Ruíz, Francisco Romero, Carmen Sáez, Miguel Á. Japón   +8 more
wiley   +1 more source

Increasing patient comfort in palliative radiotherapy with a newly developed mattress: a nonrandomized clinical trial. [PDF]

Clin Transl Radiat Oncol
Hoffmans-Holtzer N, Kunnen B, Tims O, de Pree I, Slagter C, Acht MO, Hoogeman M, Petit S.   +7 more
europepmc   +1 more source

Natulan (Procarbazine) combined with radiotherapy in management of inoperable malignant melanoma. [PDF]

, 1965
Geoffrey Falkson, Peter Villiers, H. C. Falkson, T Fichardt   +3 more
openalex   +1 more source

The critical role of DNA damage‐inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation

Molecular Oncology, EarlyView.
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li, Zhijie Cao, Haiyan Xing, Zhenya Xue, Wenbing Liu, Jiayuan Chen, Yihan Mei, Runxia Gu, Hui Wei, Shaowei Qiu, Min Wang, Qing Rao, Jianxiang Wang   +12 more
wiley   +1 more source

Moderately hypofractionated online adaptive radiotherapy (SWIFT-1) in cervical cancer patients: study protocol for a multi-centered, open-label, two-arm, phase III, randomized controlled study. [PDF]

Radiat Oncol
Zeng Z, Chen Y, Qiu J, Yang B, Wang Z, Meng X, Sun Y, Yan J, Hu K, Zhang F.   +9 more
europepmc   +1 more source

Radiotherapy for Carcinoma of the Lung [PDF]

, 1965
Ulla Beling, Jerzy Einhorn
openalex   +1 more source